Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Cost-utility analysis of molnupiravir plus usual care versus usual care alone as early treatment for community-based adults with COVID-19 and increased risk of adverse outcomes in the UK PANORAMIC trial.

Png ME. et al, (2024), Br J Gen Pract

Platform adaptive trial of novel antivirals for early treatment of COVID-19 in the community (PANORAMIC): Protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease

Gbinigie O. et al, (2023), BMJ Open, 13

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Butler CC. et al, (2023), The Lancet, 401, 281 - 293

Enhancing opportunistic recruitment and retention in primary care trials: lessons learned from a qualitative study embedded in the Cranberry for Urinary Tract Infection (CUTI) feasibility trial

Gbinigie OA. et al, (2022), BMC Primary Care, 23

Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial

Dorward J. et al, (2022), British Journal of General Practice, 72, E446 - E455

Non-antibiotic treatment of acute urinary tract infection in primary care: a qualitative study

Gbinigie OA. et al, (2022), British Journal of General Practice, 72, E252 - E260

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Yu LM. et al, (2021), The Lancet, 398, 843 - 855

Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Butler CC. et al, (2021), The Lancet Respiratory Medicine, 9, 1010 - 1020

Platform Randomised trial of INterventions against COVID-19 in older peoPLE (PRINCIPLE): Protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk

Hayward G. et al, (2021), BMJ Open, 11

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Butler CC. et al, (2021), The Lancet, 397, 1063 - 1074

The protease inhibitor lopinavir, boosted with ritonavir, as treatment for COVID-19: A rapid review

Dorward J. et al, (2021), Antiviral Therapy, 25, 365 - 376

Does cranberry extract reduce antibiotic use for symptoms of acute uncomplicated urinary tract infections (CUTI)? A feasibility randomised trial

Gbinigie O. et al, (2021), BMJ Open, 11

Colchicine for COVID-19 in adults in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial

PRINCIPLE Trial Collaborative Group None. et al, (2021)

Cranberry extract for symptoms of acute, uncomplicated urinary tract infection: A systematic review

Gbinigie OA. et al, (2021), Antibiotics, 10, 1 - 14

Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial

PRINCIPLE Collaborative Group None. et al, (2021)

PRINCIPLE trial demonstrates scope for in-pandemic improvement in primary care antibiotic stewardship: A retrospective sentinel network cohort study

de Lusignan S. et al, (2021), BJGP Open, 5, 1 - 11

PRINCIPLE trial demonstrates scope for in-pandemic improvement in primary care antibiotic stewardship

de Lusignan S. et al, (2021)

Should zinc be used for COVID-19 prophylaxis or treatment? A rapid review

Gbinigie OA. and Akyea RK., (2021), Wellcome Open Research, 5, 1 - 9

A core outcome set for pre-eclampsia research: an international consensus development study

Duffy JMN. et al, (2020), BJOG: An International Journal of Obstetrics and Gynaecology, 127, 1516 - 1526

Standardising definitions for the pre-eclampsia core outcome set: A consensus development study

Duffy JMN. et al, (2020), Pregnancy Hypertension, 21, 208 - 217

Load More